Plato Investment Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$18.3M Buy
72,416
+2,743
+4% +$639K 1.04% 14
2026
Q1
$17M Buy
69,673
+1,856
+3% +$432K 1.14% 12
2025
Q4
$14.1M Sell
67,817
-1,639
-2% -$324K 0.92% 13
2025
Q3
$12.8M Buy
69,456
+4,405
+7% +$755K 0.87% 14
2025
Q2
$9.9M Buy
65,051
+4,363
+7% +$671K 0.74% 18
2025
Q1
$10.2M Sell
60,688
-3,146
-5% -$492K 0.86% 20
2024
Q4
$9.27M Buy
63,834
+3,437
+6% +$533K 0.68% 22
2024
Q3
$9.78M Buy
60,397
+214
+0.4% +$34.1K 0.79% 18
2024
Q2
$8.8M Buy
60,183
+7,475
+14% +$1.11M 0.82% 19
2024
Q1
$8.34M Buy
52,708
+47,796
+973% +$7.61M 0.86% 20
2023
Q4
$770K Buy
+4,912
New +$753K 0.94% 20

Other funds holding JNJ

Plato Investment Management's JNJ Position: Q2 2026 in Review

Plato Investment Management increased its Johnson & Johnson (JNJ) stake by 3.9% in Q2 2026, buying an estimated $639K and bringing the position to 72,416 shares worth $18.3M. The position accounts for 1.04% of the portfolio, ranked #14.

Plato Investment Management first reported a position in JNJ in Q4 2023 and has held it in 11 quarters since. 4,655 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Plato Investment Management held 72,416 shares of Johnson & Johnson worth $18.3M as of Q2 2026.
  • Plato Investment Management bought 2,743 Johnson & Johnson shares in Q2 2026, an estimated $639K.
  • Johnson & Johnson made up 1.04% of Plato Investment Management's portfolio in Q2 2026, its #14 holding.
  • Plato Investment Management first reported a position in Johnson & Johnson in Q4 2023 and has held it in 11 quarters since.
  • 4,655 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Plato Investment Management's 13F filing for Q2 2026, filed 7 Aug 2026.